ARK ETF Trust - ARK Genomic Revolution ETF
US ˙ BATS ˙ US00214Q3020

SecurityARKG / ARK ETF Trust - ARK Genomic Revolution ETF
InstitutionCwm, Llc
Latest Disclosed Ownership35,059 shares
Latest Disclosed Value $ 926,253
Cwm, Llc reports 0.80% decrease in ownership of ARKG / ARK ETF Trust - ARK Genomic Revolution ETF

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 35,059 shares of ARK ETF Trust - ARK Genomic Revolution ETF (US:ARKG) valued at $926,259 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 35,341 shares of ARK ETF Trust - ARK Genomic Revolution ETF. This represents a change in shares of -0.80% during the quarter. The current value of the position is $1,271,590 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 35,059 -282 -0.80 926 92,500.00 0.0024
2026-01-26 2025-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 35,341 -2,192 -5.84 1 0.00 0.0028
2025-10-15 2025-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 37,533 -144 -0.38 1 0.0031
2025-07-25 2025-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 37,677 -462 -1.21 1 0.0032
2025-05-01 2025-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 38,139 3,777 10.99 1 0.0032
2025-02-04 2024-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 34,362 -3,172 -8.45 1 0.0034
2024-10-08 2024-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 37,534 -10,726 -22.23 1 -100.00 0.0041
2024-07-10 2024-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 48,260 3,432 7.66 1 0.00 0.0053
2024-04-05 2024-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 44,828 390 0.88 1 0.00 0.0063
2024-02-01 2023-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 44,438 -369 -0.82 1 0.00 0.0078
2023-10-11 2023-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 44,807 8,033 21.84 1 0.00 0.0076
2023-08-03 2023-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 36,774 8,045 28.00 1 0.0077
2023-05-01 2023-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 28,729 5,514 23.75 1 0.0058
2023-02-01 2022-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 23,215 3,685 18.87 1 -100.00 0.0048
2022-10-27 2022-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 19,530 -3,074 -13.60 642 -9.83 0.0051
2022-07-28 2022-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 22,604 -6,778 -23.07 712 -47.26 0.0055
2022-04-21 2022-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 29,382 -6,668 -18.50 1,350 -38.86 0.0096
2022-01-31 2021-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 36,050 802 2.28 2,208 -32.27 0.0155
2021-09-15 2021-06-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2021-07-29 2021-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 3,260 0.0260
2021-09-15 2021-03-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2021-04-27 2021-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 36,102 854 3,203 0.0282
2021-09-15 2020-12-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2021-01-27 2020-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 33,113 -2,135 3,088 0.0289
2021-09-15 2020-09-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2020-10-19 2020-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 31,091 -4,157 1,981 0.0220
2021-09-15 2020-06-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2020-07-22 2020-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 38,416 3,168 2,004 0.0238
2021-09-15 2020-03-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2020-04-28 2020-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 29,149 -6,099 912 0.0136
2021-09-14 2019-12-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2020-01-27 2019-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 4,414 -30,834 148 0.0019
2021-09-14 2019-09-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2021-09-14 2019-06-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 0 0.00 3,260 0.00 0.0260
2021-09-02 2019-03-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 35,248 35,248 3,260 0.0260
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.